SUSTAINN, AREV’s Ready to Use Therapeutic Foods discussed in leading article in HealthHIV
VANCOUVER, BC – TheNewswire – August 25, 2022 – AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREVF) (“AREV” or…
AREV Adds Dr. Apte to the SAB
VANCOUVER, BC – TheNewswire – August 17, 2022 – AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREVF) (“AREV” or…
AREV Corporate Update
VANCOUVER, BC / TheNewswire / August 10, 2022 / AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREVF) (“AREV” or the…
AREV Corporate Update
VANCOUVER, BC – TheNewswire – August 10, 2022 – AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREVF) (“AREV” or…
AREV Life Sciences announces acceleration of the clinical development of SUSTAINN, as further predictions of global famine increase demand for Ready to Use Therapeutic Foods (RUTF)
VANCOUVER, BC / TheNewswire / June 15, 2022 / AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREVF) (“AREV” or the…
AREV Life Sciences issues retention warrants
VANCOUVER, BC / TheNewswire / May 27, 2022 / AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREVF) (“AREV” or the…
Brian V. Elliott Joins Arev Life Sciences Global Corporation
VANCOUVER, BC / TheNewswire / April 19, 2022 / AREV Life Sciences Global Corp. (CSE:AREVF) (“AREV” or the…
Kevin Phelps, CPA Appointed Chief Operating Officer of Arev Life Sciences Global Corporation & Warrant Offering
VANCOUVER, BC / TheNewswire / April 8, 2022 / AREV Life Sciences Global Corp. (CSE:AREVF) (“AREV” or the…
AREV Life Sciences Advances Developments, New Appointments, and Relationships
VANCOUVER, BC – TheNewswire – February 17, 2022 – AREV Life Sciences Global Corp. (CSE:AREV) (“AREV” or the…
AREV SAB member Richard Van Breeman PhD publishes landmark study on CoVid19
VANCOUVER, BC –TheNewswire – January 18, 2022 – AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREVF) (“AREV” or the…